https://pulsenews.co.kr/view.php?sc=30800024&year=2021&no=555949
SK hynix files libel charges over the rumor of defective products
SK hynix Inc denied a rumor that it is facing damages worth 2 trillion won from clients over defective DRAMs amounting to 240,000 wafers and has filed libel and misinformation charges with Icheon police.
The rumor has been circulating since Monday on social media such as Kakao Talk and the Blind app.
South Korea's No. 2 chipmaker confirmed that it was discussing defect issues in a few DRAM products with a limited number of customers but emphasized that the issues were overblown.
SK hynix noted that the defect is within the range of a typical quality issue check.
With the damage done to SK hynix’s reputation way more than the impact of the defects, it requested a police probe over the matter.
SK hynix produces around 1.8 million wafers a month, with about 80 percent dedicated to DRAM.


Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Gold Prices Drop Amid Iran War Concerns, Rising Oil Costs, and Hawkish Central Bank Signals
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
European Stocks Slip as U.S.-Iran Tensions and Earnings Season Weigh on Markets
BOJ Rate Decision in Focus as Yen, Inflation, and Nikkei Hang in Balance
Google Secures Pentagon AI Deal for Classified Projects
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
Global PCB Prices Surge Amid Middle East Conflict and Supply Chain Disruptions
Trump Administration Sues Three States Over Prediction Market Regulations
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
DOJ Launches Antitrust Investigation Into the NFL Over Broadcast Restrictions
Oil Prices Rise Amid U.S.-Iran Tensions and Strait of Hormuz Deadlock
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales 



